Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Smoking Cessation and Harm Reduction Approaches Among People Living With HIV/AIDS in South Africa

NCT06169813 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT06169813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06169813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Smoking Cessation and Harm Reduction Approaches Among People Living With HIV/AIDS in South Africa
Lead sponsor
NYU Langone Health
Phase
Phase 1
Overall status
Completed
Start date
April 15, 2025
Completion date
March 19, 2026
Enrollment
106 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tobacco smoking